Biolife Solutions (BLFS) EPS (Weighted Average and Diluted) (2017 - 2025)
Historic EPS (Weighted Average and Diluted) for Biolife Solutions (BLFS) over the last 11 years, with Q3 2025 value amounting to $0.01.
- Biolife Solutions' EPS (Weighted Average and Diluted) rose 12500.0% to $0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.06, marking a year-over-year increase of 9423.08%. This contributed to the annual value of -$0.19 for FY2024, which is 8768.0% up from last year.
- Per Biolife Solutions' latest filing, its EPS (Weighted Average and Diluted) stood at $0.01 for Q3 2025, which was up 12500.0% from -$0.33 recorded in Q2 2025.
- Biolife Solutions' 5-year EPS (Weighted Average and Diluted) high stood at $0.32 for Q4 2024, and its period low was -$1.72 during Q2 2022.
- In the last 5 years, Biolife Solutions' EPS (Weighted Average and Diluted) had a median value of -$0.24 in 2022 and averaged -$0.33.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first plummeted by 100526.32% in 2022, then soared by 19614.44% in 2024.
- Over the past 5 years, Biolife Solutions' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.4 in 2021, then crashed by 177.5% to -$1.11 in 2022, then surged by 70.27% to -$0.33 in 2023, then skyrocketed by 196.14% to $0.32 in 2024, then plummeted by 96.85% to $0.01 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $0.01 for Q3 2025, versus -$0.33 for Q2 2025 and -$0.01 for Q1 2025.